Chemistree Technology Inc. (CSE: CHM) (USOTCQB: CHMJF) (the “Company” or “Chemistree“), is providing Notice of the semi-annual…
Blog
Deka Biosciences, Inc Announces Submission of Investigational New Drug (IND) Application for Lead Oncology Asset, DK210 (EGFR)
Today, Deka Biosciences, Inc. (Deka), a biotech company focused on developing novel cytokine therapies to treat…
Bone Growth Stimulators Market Research Report by Product, Application, Distribution Channel, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19
The Global Bone Growth Stimulators Market size was estimated at USD 2,189.34 million in 2021 and expected to…
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
Berkeley Lights (Nasdaq: BLI), a life sciences tools company, and IsoPlexis (Nasdaq: ISO), a company empowering labs to…
Mirati Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
Mirati Therapeutics, Inc. (NASDAQ: MRTX), a commercial-stage targeted oncology company, today announced that the Company will present at…
ATI Physical Therapy Names Healthcare Partnerships Leader Scott Gregerson as Chief Growth Officer
ATI Physical Therapy, Inc. (“ATI” or the “Company”) (NYSE: ATIP), the largest single-branded outpatient physical therapy provider in the United…
Northwest Tribes Celebrate Historic Congressional Funding Provision for Indian Health Service
Today, Congress passed the $1.7 trillion fiscal 2023 spending package, which included $5.1 billion in advance appropriations for the Indian…
Body Contouring Devices Global Market Report 2022: Wide Acceptance of Aesthetic Procedures and Increased Focus on Body Image and Appearance Bolsters Sector
The “Body Contouring Devices Market – Global Outlook and Forecast 2022-2027”report has been added to ResearchAndMarkets.com’s offering. The global…
IceCure Medical Ltd. Announces Closing of $14.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), developer of minimally-invasive cryoablation technology, the…
Clinical Trial Approval For The Company’s Novel Adjuvanted Recombinant Shingles Vaccine REC610 In The Philippines
Jiangsu Recbio Technology Co., Ltd. (the “Company”, together with its subsidiaries, the “Group”) is pleased to…